Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Recenti Progressi in Medicina
|
December 20, 2002
[Anemia induced by solid tumor chemotherapy]
Roberto Stasi, Luca Abriani, Patrizia Beccaglia, et al.
Cancer
|
October 30, 2003
Cancer-related fatigue: evolving concepts in evaluation and treatment
Roberto Stasi, Luca Abriani, Patrizia Beccaglia, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2004
A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer
Ottavio Ariganello, Andrea Mancuso, Michele Di Molfetta, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Disability weights for castration-resistant prostate cancer: an empirical investigation
Ludovica Borsoi, Oriana Ciani, Rocco De Vivo, et al.
The Oncologist
|
July 22, 2004
Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy
Enrico Cortesi, Andrea Mancuso, Adolfo De Pasquale Ceratti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 14, 2007
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly
Giacomo Cartenì, Laura Giannetta, Giovanni Ucci, et al.
Critical Reviews in Oncology/Hematology
|
September 9, 2008
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients
Fabio Puglisi, Laura Deroma, Stefania Russo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2007
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth
Roberto Bianchi, Alessandra Gilardini, Virginia Rodriguez-Menendez, et al.
Journal of Bone Oncology
|
January 11, 2021
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE
Daniele Santini, Saverio Cinieri, Donatello Gasparro, et al.
Therapeutic Advances in Medical Oncology
|
November 16, 2020
Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study
Giuseppe Procopio, Vincenzo Emanuele Chiuri, Monica Giordano, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Recenti Progressi in Medicina
|
December 20, 2002
[Anemia induced by solid tumor chemotherapy]
Roberto Stasi, Luca Abriani, Patrizia Beccaglia, et al.
Cancer
|
October 30, 2003
Cancer-related fatigue: evolving concepts in evaluation and treatment
Roberto Stasi, Luca Abriani, Patrizia Beccaglia, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 15, 2004
A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer
Ottavio Ariganello, Andrea Mancuso, Michele Di Molfetta, et al.
Global & Regional Health Technology Assessment
|
January 11, 2023
Disability weights for castration-resistant prostate cancer: an empirical investigation
Ludovica Borsoi, Oriana Ciani, Rocco De Vivo, et al.
The Oncologist
|
July 22, 2004
Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy
Enrico Cortesi, Andrea Mancuso, Adolfo De Pasquale Ceratti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 14, 2007
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly
Giacomo Cartenì, Laura Giannetta, Giovanni Ucci, et al.
Critical Reviews in Oncology/Hematology
|
September 9, 2008
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients
Fabio Puglisi, Laura Deroma, Stefania Russo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2007
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth
Roberto Bianchi, Alessandra Gilardini, Virginia Rodriguez-Menendez, et al.
Journal of Bone Oncology
|
January 11, 2021
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE
Daniele Santini, Saverio Cinieri, Donatello Gasparro, et al.
Therapeutic Advances in Medical Oncology
|
November 16, 2020
Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study
Giuseppe Procopio, Vincenzo Emanuele Chiuri, Monica Giordano, et al.
Page
of 2